Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-13

Clinical Trial Update: Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating armodafinil for fatigue management in patients with primary brain tumors undergoing radiation therapy; study completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Armodafinil (armodafinil)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Brain Tumors, Nervous System Tumors | Phase 2 | Status: COMPLETED | Results posted: 2017-02-13